Snowden Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-69,145
| Closed | -$2.27M | – | 1172 |
|
|
2023
Q4 | $2.27M | Sell |
69,145
-1,337
| -2% | -$43.9K | 0.09% | 264 |
|
|
2023
Q3 | $1.96M | Sell |
70,482
-2,070
| -3% | -$57.7K | 0.08% | 273 |
|
|
2023
Q2 | $2.47M | Sell |
72,552
-929
| -1% | -$31.7K | 0.09% | 256 |
|
|
2023
Q1 | $2.21M | Sell |
73,481
-28,420
| -28% | -$855K | 0.09% | 265 |
|
|
2022
Q4 | $2.88M | Sell |
101,901
-1,714
| -2% | -$48.4K | 0.12% | 214 |
|
|
2022
Q3 | $3.41M | Sell |
103,615
-3,496
| -3% | -$115K | 0.15% | 171 |
|
|
2022
Q2 | $3.37M | Sell |
107,111
-101
| -0.1% | -$3.18K | 0.15% | 180 |
|
|
2022
Q1 | $4.92M | Buy |
107,212
+3,358
| +3% | +$154K | 0.2% | 137 |
|
|
2021
Q4 | $6.36M | Buy |
103,854
+255
| +0.2% | +$15.6K | 0.32% | 78 |
|
|
2021
Q3 | $7.74M | Buy |
103,599
+2,064
| +2% | +$154K | 0.39% | 57 |
|
|
2021
Q2 | $9.39M | Buy |
101,535
+1,358
| +1% | +$126K | 0.47% | 39 |
|
|
2021
Q1 | $8.89M | Buy |
100,177
+2,192
| +2% | +$194K | 0.51% | 30 |
|
|
2020
Q4 | $9.14M | Buy |
97,985
+20,632
| +27% | +$1.92M | 0.6% | 26 |
|
|
2020
Q3 | $4.93M | Sell |
77,353
-79,969
| -51% | -$5.09M | 0.39% | 70 |
|
|
2020
Q2 | $8.21M | Buy |
157,322
+24,978
| +19% | +$1.3M | 0.7% | 22 |
|
|
2020
Q1 | $4.14M | Buy |
132,344
+13,734
| +12% | +$430K | 0.45% | 51 |
|
|
2019
Q4 | $3.98M | Buy |
118,610
+5,762
| +5% | +$193K | 0.35% | 79 |
|
|
2019
Q3 | $3.33M | Sell |
112,848
-8,652
| -7% | -$255K | 0.34% | 93 |
|
|
2019
Q2 | $4.19M | Buy |
121,500
+38,895
| +47% | +$1.34M | 0.43% | 60 |
|
|
2019
Q1 | $2.72M | Buy |
82,605
+20,064
| +32% | +$660K | 0.3% | 113 |
|
|
2018
Q4 | $1.5M | Buy |
62,541
+10,535
| +20% | +$253K | 0.19% | 180 |
|
|
2018
Q3 | $1.74M | Buy |
+52,006
| New | +$1.74M | 0.2% | 167 |
|